Thus, high circulating levels of IL-6 could reflect the intensity of obesity-associated chronic and systemic inflammation, which in turn might contribute to the development of atherosclerosis and CHD, both directly and by reducing HDL cholesterol levels [44]. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.